GT Biopharma (OXIA.F) Q1 2025 Earnings

21FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-2.56
-2.19
-1.82
-1.45

Details

Expected EPS
-1.481335
Actual EPS
-1.5960189999999999
Surprise EPS
-0.11
Surprise Percent
+7.74%

Description

GT Biopharma (OXIA.F) has reported earnings of -1.5960189999999999 per share for Q1 2025.

0 Comments

Share your thoughts